Bellevue Healthcare (BBH) Competitors GBX 115.60 -2.60 (-2.20%) As of 04/17/2025 12:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BBH vs. N91, TFG, LWDB, VEIL, FCSS, GSS, ASL, JMG, EDIN, and JPEShould you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Ninety One Group (N91), Tetragon Financial (TFG), Law Debenture (LWDB), Vietnam Enterprise (VEIL), Fidelity China Special (FCSS), Genesis Emerging Markets Fund (GSS), Aberforth Smaller Companies Trust (ASL), JPMorgan Emerging Markets (JMG), Edinburgh Investment (EDIN), and JPMorgan Elect plc - Managed Growth (JPE). These companies are all part of the "asset management" industry. Bellevue Healthcare vs. Ninety One Group Tetragon Financial Law Debenture Vietnam Enterprise Fidelity China Special Genesis Emerging Markets Fund Aberforth Smaller Companies Trust JPMorgan Emerging Markets Edinburgh Investment JPMorgan Elect plc - Managed Growth Bellevue Healthcare (LON:BBH) and Ninety One Group (LON:N91) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations. Is BBH or N91 a better dividend stock? Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.2%. Ninety One Group pays an annual dividend of GBX 12 per share and has a dividend yield of 8.7%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Ninety One Group pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has preferable valuation and earnings, BBH or N91? Ninety One Group has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Ninety One Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBellevue Healthcare-£9.60M-29.69-£16.23M-£6.57-17.58Ninety One Group£586.81M2.07£154.01M£17.377.92 Do analysts prefer BBH or N91? Ninety One Group has a consensus target price of GBX 173, suggesting a potential upside of 25.82%. Given Ninety One Group's stronger consensus rating and higher possible upside, analysts clearly believe Ninety One Group is more favorable than Bellevue Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bellevue Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ninety One Group 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer BBH or N91? In the previous week, Bellevue Healthcare's average media sentiment score of 0.00 equaled Ninety One Group'saverage media sentiment score. Company Overall Sentiment Bellevue Healthcare Neutral Ninety One Group Neutral Does the MarketBeat Community believe in BBH or N91? Bellevue Healthcare received 109 more outperform votes than Ninety One Group when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 13.33% of users gave Ninety One Group an outperform vote. CompanyUnderperformOutperformBellevue HealthcareOutperform Votes11168.52% Underperform Votes5131.48% Ninety One GroupOutperform Votes213.33%Underperform Votes1386.67% Is BBH or N91 more profitable? Bellevue Healthcare has a net margin of 169.10% compared to Ninety One Group's net margin of 26.24%. Ninety One Group's return on equity of 42.90% beat Bellevue Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Bellevue Healthcare169.10% -4.48% N/A Ninety One Group 26.24%42.90%1.15% Do insiders and institutionals hold more shares of BBH or N91? 40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 26.8% of Ninety One Group shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by company insiders. Comparatively, 58.3% of Ninety One Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryNinety One Group beats Bellevue Healthcare on 11 of the 16 factors compared between the two stocks. Get Bellevue Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBH vs. The Competition Export to ExcelMetricBellevue HealthcareAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£284.91M£1.09B£3.66B£2.48BDividend Yield3.82%4.43%4.20%4.96%P/E Ratio-17.5823.6314.01129.75Price / Sales-29.692,224.361,657.54232,042.22Price / CashN/A60.9450.1928.07Price / Book0.771.103.334.43Net Income-£16.23M£260.34M£1.23B£5.83B7 Day Performance1.58%2.64%2.01%3.01%1 Month Performance-7.81%1.67%0.62%-1.06%1 Year Performance-18.59%1.56%9.70%102.51% Bellevue Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBHBellevue HealthcareN/AGBX 115.60-2.2%N/A-18.6%£284.91M£-9,595,061.74-17.58N/AGap UpN91Ninety One GroupN/AGBX 125.60+4.6%GBX 173+37.7%-17.7%£1.11B£586.81M7.231,180Gap UpTFGTetragon FinancialN/AGBX 13.67+1.3%N/A+41.0%£1.11B£22.12B8.77N/ALWDBLaw DebentureN/AGBX 820+4.1%N/A+7.7%£1.08B£203.87M7.63260News CoverageHigh Trading VolumeVEILVietnam EnterpriseN/AGBX 471-1.6%N/A-10.2%£1.08B£17.87M-318.13N/ANews CoverageFCSSFidelity China SpecialN/AGBX 216.50+0.9%N/A+11.5%£1.07B£-177,570,734.591.07N/AGap DownGSSGenesis Emerging Markets FundN/AN/AN/AN/A£1.06B£250.40M6.181,626Gap DownASLAberforth Smaller Companies TrustN/AGBX 1,254.06+3.5%N/A-2.9%£1.05B£226.05M4.12N/ANews CoveragePositive NewsHigh Trading VolumeJMGJPMorgan Emerging MarketsN/AGBX 97.10+1.9%N/A-1.9%£1.03B£97.45M12.86N/AInsider TradeNews CoverageGap DownHigh Trading VolumeEDINEdinburgh InvestmentN/AGBX 698+2.6%N/A+7.5%£1.01B£189.32M5.58N/AJPEJPMorgan Elect plc - Managed GrowthN/AN/AN/AN/A£1.00B£104.78M1,250.00N/A Related Companies and Tools Related Companies Ninety One Group Alternatives Tetragon Financial Alternatives Law Debenture Alternatives Vietnam Enterprise Alternatives Fidelity China Special Alternatives Genesis Emerging Markets Fund Alternatives Aberforth Smaller Companies Trust Alternatives JPMorgan Emerging Markets Alternatives Edinburgh Investment Alternatives JPMorgan Elect plc - Managed Growth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BBH) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Healthcare Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.